{"id": "236565", "url": "https://fevir.net/resources/Evidence/236565", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-only-evidence"], "versionId": "66", "lastUpdated": "2025-10-07T17:12:54.639Z"}, "name": "Health_related_quality_of_life_Comparator_Evidence_from_MAGICapp_109569", "title": "MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in Standard care Group in Adults with type 2 diabetes with moderate CV risk", "author": [{"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}], "citeAs": "MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in Standard care Group in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing\u00ae: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236565. Revised 2025-10-07. Available at: https://fevir.net/resources/Evidence/236565. Computable resource at: https://fevir.net/resources/Evidence/236565#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "publisher": "Computable Publishing LLC", "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-conversion-report", "assigner": {"display": "Computable Publishing LLC"}}}}], "statistic": [{"quantity": {"value": 51}, "description": "MEAN 51", "statisticType": {"coding": [{"code": "STATO:0000573", "system": "https://fevir.net/sevco", "display": "mean"}]}, "attributeEstimate": [{"type": {"text": "SD"}, "quantity": {"value": 7}, "description": "SD 7.0"}]}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "236565", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "outcomeId"}, "value": "109569", "system": "https://app.magicapp.org/#/guidelines"}, {"type": {"text": "picoId"}, "value": "85789", "system": "https://app.magicapp.org/#/guidelines"}, {"type": {"text": "sectionId"}, "value": "73212", "system": "https://app.magicapp.org/#/guidelines"}], "useContext": [{"code": {"code": "evidence-communication", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"code": "ComparatorOnlyEvidence", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "ComparatorOnlyEvidence"}]}}], "studyDesign": [{"text": "PRIMARY_STUDY"}], "resourceType": "Evidence", "synthesisType": [{"text": "NOTSET"}], "variableDefinition": [{"observed": {"type": "Group", "display": "Standard care Group in Adults with type 2 diabetes with moderate CV risk", "reference": "Group/236534", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-comparator-85390-C-85789", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "description": "Adults with type 2 diabetes with moderate CV risk -- Standard care", "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Health-related quality of life", "reference": "EvidenceVariable/236563", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "MAGIC-5288-j1Wqrn-109569", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "description": "Health-related quality of life", "variableRole": "outcome"}], "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}